{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T11:21:48Z","timestamp":1790248908426,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,7]]},"DOI":"10.7759\/cureus.30047","type":"journal-article","created":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T04:44:18Z","timestamp":1665204258000},"source":"Crossref","is-referenced-by-count":2,"title":["Assessment of Additional Risk Factors for Cardiovascular Disease and Awareness Among Adult Patients With Diabetes Mellitus: A Cross-Sectional Study From Northern Sri Lanka"],"prefix":"10.7759","author":[{"given":"Printhiny","family":"Manoharan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeshkannan","family":"Nadarajah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navaneethakrishnan","family":"Suganthan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4038\/cmj.v51i1.1373","article-title":"The diabetes epidemic in Sri Lanka - a growing problem","volume":"51","author":"Katulanda P","year":"2006","unstructured":"Katulanda P, Sheriff MH, Matthews DR. The diabetes epidemic in Sri Lanka - a growing problem. Ceylon Med J. 2006, 51:26-28. 10.4038\/cmj.v51i1.1373","journal-title":"Ceylon Med J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)60484-9","article-title":"Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies","volume":"375","author":"Sarwar N","year":"2010","unstructured":"Sarwar N, Gao P, Seshasai SR, et al.. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010, 375:2215-2222. 10.1016\/S0140-6736(10)60484-9","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4038\/sjdem.v5i2.7282","article-title":"Cardiovascular disease: the leading cause of diabetes related mortality","volume":"5","author":"Amarawardena WG","year":"2015","unstructured":"Amarawardena WG, Siyambalapitiya S, Subasinghe SCJ. Cardiovascular disease: the leading cause of diabetes related mortality. Sri Lanka J Diabetes Endocrin Metab. 2015, 5:63-64. 10.4038\/sjdem.v5i2.7282","journal-title":"Sri Lanka J Diabetes Endocrin Metab"},{"key":"ref4","article-title":"Dyslipidaemia in type 2 diabetes: cardiovascular risk assessment and management","volume":"21","author":"Lan NR","year":"2020","unstructured":"Lan NR, Burns K, Bell DA, Watts GF. Dyslipidaemia in type 2 diabetes: cardiovascular risk assessment and management. Med Today. 2020, 21:4-12.","journal-title":"Med Today"},{"key":"ref5","article-title":"Reducing cardiovascular risk in type 2 diabetes: can we do more?","volume":"19","author":"Sindone A","year":"2018","unstructured":"Sindone A, Chen R. Reducing cardiovascular risk in type 2 diabetes: can we do more?. Med Today. 2018, 19:34-39.","journal-title":"Med Today"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4038\/sjdem.v9i1.7372","article-title":"Factors affecting cardiovascular risk in patients with type 2 diabetes mellitus; a clinic based study","author":"Rathnayake RK","year":"2019","unstructured":"Rathnayake RK, Rathnayake T, Rathnayake RB, Abewardana TL\r\n. Factors affecting cardiovascular risk in patients with type 2 diabetes mellitus; a clinic based study. Sri Lanka J Diabetes Endocrin. 2019, 26-32. 10.4038\/sjdem.v9i1.7372","journal-title":"Sri Lanka J Diabetes Endocrin"},{"key":"ref7","article-title":"Sample size determination in health studies: a practical manual","author":"Lwanga SK","year":"1991","unstructured":"Lwanga SK, Lemeshow S. Sample size determination in health studies: a practical manual. World Health Organization, 1991."},{"key":"ref8","unstructured":"Current status of cancer in Jaffna district. completeness of registration and prevalence of risk factors and awareness of preventive services. (2010). http:\/\/librepository.pgim.cmb.ac.lk\/handle\/1\/1043."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s40795-020-00391-2","article-title":"Relative validity of a brief dietary survey to assess food intake and adherence to national dietary guidelines among Sri Lankan adults","volume":"6","author":"Renzella J","year":"2020","unstructured":"Renzella J, Fernando S, Kalupahana B, et al.. Relative validity of a brief dietary survey to assess food intake and adherence to national dietary guidelines among Sri Lankan adults. BMC Nutr. 2020, 6:68. 10.1186\/s40795-020-00391-2","journal-title":"BMC Nutr"},{"key":"ref10","unstructured":"World Health Organization. STEPwise approach to NCD risk factor surveillance (STEPS). (2020). Accessed: December 5, 2021: https:\/\/www.who.int\/teams\/noncommunicable-diseases\/surveillance\/systems-tools\/steps."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2019.107843","article-title":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition","volume":"157","author":"Saeedi P","year":"2019","unstructured":"Saeedi P, Petersohn I, Salpea P, et al.. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019, 157:107843. 10.1016\/j.diabres.2019.107843","journal-title":"Diabetes Res Clin Pract"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.18231\/j.pjms.2021.028","article-title":"A retrospective evaluation of the trend of prevalence of type 2 diabetes mellitus in different age groups in a tertiary care hospital","volume":"11","author":"Patel B","year":"2021","unstructured":"Patel B, Patel C, Panchal D, Patel S. A retrospective evaluation of the trend of prevalence of type 2 diabetes mellitus in different age groups in a tertiary care hospital. Panacea J Med Sci. 2021, 11:130-133. 10.18231\/j.pjms.2021.028","journal-title":"Panacea J Med Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v6.i13.1246","article-title":"Diabetes and cardiovascular disease: Epidemiology, biological mechanisms, treatment recommendations and future research","volume":"6","author":"Leon BM","year":"2015","unstructured":"Leon BM, Maddox TM. Diabetes and cardiovascular disease: Epidemiology, biological mechanisms, treatment recommendations and future research. World J Diabetes. 2015, 6:1246-1258. 10.4239\/wjd.v6.i13.1246","journal-title":"World J Diabetes"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1177\/1010539517709028","article-title":"Differentials in cardiovascular risk factors and diabetes by socioeconomic status and sex in Kalutara, Sri Lanka","volume":"29","author":"Gamlath L","year":"2017","unstructured":"Gamlath L, Nandasena S, Hennadige Padmal de Silva S, et al.. Differentials in cardiovascular risk factors and diabetes by socioeconomic status and sex in Kalutara, Sri Lanka. Asia Pac J Public Health. 2017, 29:401-410. 10.1177\/1010539517709028","journal-title":"Asia Pac J Public Health"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2009.01.029","article-title":"Global variability in fruit and vegetable consumption","volume":"36","author":"Hall JN","year":"2009","unstructured":"Hall JN, Moore S, Harper SB, Lynch JW. Global variability in fruit and vegetable consumption. Am J Prev Med. 2009, 36:402-409. 10.1016\/j.amepre.2009.01.029","journal-title":"Am J Prev Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1249\/MSS.0000000000001939","article-title":"Physical activity, all-cause and cardiovascular mortality, and cardiovascular disease","volume":"51","author":"Kraus WE","year":"2019","unstructured":"Kraus WE, Powell KE, Haskell WL, et al.. Physical activity, all-cause and cardiovascular mortality, and cardiovascular disease. Med Sci Sports Exerc. 2019, 51:1270-1281. 10.1249\/MSS.0000000000001939","journal-title":"Med Sci Sports Exerc"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.28.8.1965","article-title":"Glycemic control, atherosclerosis, and risk factors for cardiovascular disease in individuals with diabetes: the atherosclerosis risk in communities study","volume":"28","author":"Selvin E","year":"2005","unstructured":"Selvin E, Coresh J, Golden SH, Boland LL, Brancati FL, Steffes MW. Glycemic control, atherosclerosis, and risk factors for cardiovascular disease in individuals with diabetes: the atherosclerosis risk in communities study. Diabetes Care. 2005, 28:1965-1973. 10.2337\/diacare.28.8.1965","journal-title":"Diabetes Care"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/6450281","article-title":"Factors associated with visit-to-visit variability of blood pressure measured as part of routine clinical care among patients attending cardiology outpatient department of a tertiary care centre in Northern Sri Lanka","volume":"2019","author":"Kumanan T","year":"2019","unstructured":"Kumanan T, Sujanitha V, Guruparan M, Rajeshkannan N. Factors associated with visit-to-visit variability of blood pressure measured as part of routine clinical care among patients attending cardiology outpatient department of a tertiary care centre in Northern Sri Lanka. Int J Hypertens. 2019, 2019:6450281. 10.1155\/2019\/6450281","journal-title":"Int J Hypertens"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-S003","article-title":"Standards of medical care in diabetes-2016: summary of revisions","volume":"39","year":"2016","unstructured":"Standards of medical care in diabetes-2016. summary of revisions. Diabetes Care. 2016, 39:S4-S5. 10.2337\/dc16-S003","journal-title":"Diabetes Care"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1177\/1479164114525548","article-title":"ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - summary","volume":"11","author":"Ryd\u00e9n L","year":"2014","unstructured":"Ryd\u00e9n L, Grant PJ, Anker SD, et al.. ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - summary. Diab Vasc Dis Res. 2014, 11:133-173. 10.1177\/1479164114525548","journal-title":"Diab Vasc Dis Res"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3390\/nu11091970","article-title":"Sodium intake and hypertension","volume":"11","author":"Grillo A","year":"2019","unstructured":"Grillo A, Salvi L, Coruzzi P, Salvi P, Parati G. Sodium intake and hypertension. Nutrients. 2019, 11:10.3390\/nu11091970","journal-title":"Nutrients"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108194","article-title":"Cardiovascular diseases and risk factors knowledge and awareness in people with type 2 diabetes mellitus: a global evaluation","volume":"165","author":"Saeedi P","year":"2020","unstructured":"Saeedi P, Karuranga S, Hammond L, Kaundal A, Malanda B, Prystupiuk M, Matos P. Cardiovascular diseases and risk factors knowledge and awareness in people with type 2 diabetes mellitus: a global evaluation. Diabetes Res Clin Pract. 2020, 165:108194. 10.1016\/j.diabres.2020.108194","journal-title":"Diabetes Res Clin Pract"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.28.3.595","article-title":"Adherence to statin therapy and LDL cholesterol goal attainment by patients with diabetes and dyslipidemia","volume":"28","author":"Parris ES","year":"2005","unstructured":"Parris ES, Lawrence DB, Mohn LA, Long LB. Adherence to statin therapy and LDL cholesterol goal attainment by patients with diabetes and dyslipidemia. Diabetes Care. 2005, 28:595-599. 10.2337\/diacare.28.3.595","journal-title":"Diabetes Care"},{"key":"ref24","article-title":"Aspirin therapy in diabetes: evidence and current recommendations","volume":"21","author":"Szwarcbard N","year":"2020","unstructured":"Szwarcbard N, Zoungas S. Aspirin therapy in diabetes: evidence and current recommendations. Med Today. 2020, 21:30-32.","journal-title":"Med Today"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2008.623","article-title":"Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial","volume":"300","author":"Ogawa H","year":"2008","unstructured":"Ogawa H, Nakayama M, Morimoto T, et al.. Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial. JAMA. 2008, 300:2134-2141. 10.1001\/jama.2008.623","journal-title":"JAMA"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2009.09.029","article-title":"Aspirin for primary prevention of cardiovascular events in patients with diabetes: a meta-analysis","volume":"87","author":"Zhang C","year":"2010","unstructured":"Zhang C, Sun A, Zhang P, et al.. Aspirin for primary prevention of cardiovascular events in patients with diabetes: a meta-analysis. Diabetes Res Clin Pract. 2010, 87:211-218. 10.1016\/j.diabres.2009.09.029","journal-title":"Diabetes Res Clin Pract"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.20578","article-title":"Association of aspirin use for primary prevention with cardiovascular events and bleeding events: a systematic review and meta-analysis","volume":"321","author":"Zheng SL","year":"2019","unstructured":"Zheng SL, Roddick AJ. Association of aspirin use for primary prevention with cardiovascular events and bleeding events: a systematic review and meta-analysis. JAMA. 2019, 321:277-287. 10.1001\/jama.2018.20578","journal-title":"JAMA"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso SP","year":"2016","unstructured":"Marso SP, Bain SC, Consoli A, et al.. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. N Engl J Med. 2016, 375:1834-1844. 10.1056\/NEJMoa1607141","journal-title":"N Engl J Med"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31149-3","article-title":"Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial","volume":"394","author":"Gerstein HC","year":"2019","unstructured":"Gerstein HC, Colhoun HM, Dagenais GR, et al.. Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial. Lancet. 2019, 394:121-130. 10.1016\/S0140-6736(19)31149-3","journal-title":"Lancet"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman B","year":"2015","unstructured":"Zinman B, Wanner C, Lachin JM, et al.. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med. 2015, 373:2117-2128. 10.1056\/NEJMoa1504720","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/113600-assessment-of-additional-risk-factors-for-cardiovascular-disease-and-awareness-among-adult-patients-with-diabetes-mellitus-a-cross-sectional-study-from-northern-sri-lanka","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:50:35Z","timestamp":1707508235000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/113600-assessment-of-additional-risk-factors-for-cardiovascular-disease-and-awareness-among-adult-patients-with-diabetes-mellitus-a-cross-sectional-study-from-northern-sri-lanka"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,7]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.30047","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10,7]]}}}